SDS Inventory logo
Safety Data Sheet Chemical Risk Assessment

Augmentin Tablets

by GlaxoSmithKline US

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

AUGMENTIN TABLETS is supplied by GlaxoSmithKline US under product code AUGMENTIN 156.25 MG TABLETS, AUGMENTIN 250 MG TABLETS, AUGMENTIN 500 MG TABLETS, AUGMENTIN 187.5 MG TABLETS, AUGMENTIN 375 MG TABLETS, AUGMENTIN 625 MG TABLETS, AUGMENTAN TABLETS, AUGMENTIN 2:1 TABLETS, AUGMENTIN 4:1 TABLETS, CLAVULIN 250 TABLETS, CLAVULIN 500F TABLETS, AMOCLAV 375 MG TABLETS, AMOCLAV 625 MG TABLETS, CLAMOXYL TABLETS 250 MG, SPEKTRAMOX 375 MG FINAL TABLETS, NDC NO. 0029-6075-27, NDC NO. 0029-6075-31, NDC NO. 0029-6080-12, NDC NO. 0029-6080-31, AMOXICILLIN TRIHYDRATE AND POTASSIUM CLAVULANATE, FORMULATED PRODUCT. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under OSHA regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 7 November 2014. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.

Language
English
Regulation
OSHA
Revision Date
07 Nov 2014
Signal Word
WARNING
Product Code
AUGMENTIN 156.25 MG TABLETS, AUGMENTIN 250 MG TABLETS, AUGMENTIN 500 MG TABLETS, AUGMENTIN 187.5 MG TABLETS, AUGMENTIN 375 MG TABLETS, AUGMENTIN 625 MG TABLETS, AUGMENTAN TABLETS, AUGMENTIN 2:1 TABLETS, AUGMENTIN 4:1 TABLETS, CLAVULIN 250 TABLETS, CLAVULIN 500F TABLETS, AMOCLAV 375 MG TABLETS, AMOCLAV 625 MG TABLETS, CLAMOXYL TABLETS 250 MG, SPEKTRAMOX 375 MG FINAL TABLETS, NDC NO. 0029-6075-27, NDC NO. 0029-6075-31, NDC NO. 0029-6080-12, NDC NO. 0029-6080-31, AMOXICILLIN TRIHYDRATE AND POTASSIUM CLAVULANATE, FORMULATED PRODUCT
CAS Number
61336-70-7,9004-34-6,9063-38-1,557-04-0,31-86-9

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a Glance From the Safety Data Sheet
Signal Word: WARNING
Hazard Statements (H-phrases)
+NO
See full Safety Data Sheet for the hazard statement wording.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.

Download SDS
Common Questions About this Safety Data Sheet
This Safety Data Sheet was issued by GlaxoSmithKline US on 7 November 2014 under OSHA. ISDSS syncs its database regularly to keep documents current.
Yes, a free ISDSS account is required to download the PDF. Registration takes under two minutes and gives you access to over 1.5 million Safety Data Sheets. Once registered, you can also save documents to your personal library for quick access.
The manufacturer, importer or supplier that places the substance on the market is responsible for providing a current Safety Data Sheet to downstream users, free of charge.
No. An SDS provides the hazard information you need, but a COSHH assessment must consider how the substance is actually used in your workplace. The matching Chemical Risk Assessment (CRA) on this page is a starting point you should adapt to your own tasks and controls.
Chemical Risk Assessment Summary From the Chemical Risk Assessment
Assessment Summary
This Chemical Risk Assessment is derived from the Safety Data Sheet for Augmentin Tablets issued by Glaxosmithkline Us on 7 November 2014 It presents the substance's hazards organised by risk level, with the relevant regulatory statements and recommended controls for each.
Hazard Preview A snapshot of substance hazards and controls
Note: This is a preview of the substance's hazards. A substance commonly carries more hazards. Download the full Chemical Risk Assessment for more information.
Recommended Control Measures Key PPE and handling controls

Need to download the Chemical Risk Assessment? The full CRA PDF includes all hazard classifications, regulatory statements and recommended controls.

Download CRA
Common Questions About this Risk Assessment
This Chemical Risk Assessment provides the substance-level hazard inputs needed for a COSHH assessment under the UK Control of Substances Hazardous to Health Regulations 2002. It is not a substitute for a full workplace risk assessment. You must combine this with your own assessment of how the substance is actually used on your site, including task specifics, exposure duration and local controls.
The CRA is derived from the hazard data in the manufacturer's SDS for Augmentin Tablets, mapped against standard workplace task profiles. It is updated in line with SDS revisions. The CRA is a starting point for your own assessment, not a finished document.
A Safety Data Sheet is produced by the manufacturer and describes the hazards of the substance itself. A Chemical Risk Assessment evaluates those hazards in the context of how the substance is actually used in the workplace, covering specific tasks, exposure routes and recommended controls. Both documents work together.
Yes, a free ISDSS account gives you access to both the SDS and the linked CRA for over 1.5 million substances. Registration takes under two minutes.
Need help with Safety Data Sheets? You've come to the right place!

2026 © Copyright International Safety Data Sheet Service™

Wait... This is Important!

Find an array of safety data sheets for various materials here.

Simply type in a keyword below, and we'll take care of the rest! Maintain safety in the workplace today!

Back to top